TenNor Therapeutics
Zhenkun Ma is the current CEO and founder of TenNor Therapeutics. Zhenkun has over twenty years of experience in the pharmaceutical industry. Prior to their current position, they served as Chief Science Officer at TB Alliance from January 2004 to December 2013. From January 2002 to December 2004, they were Director at Cumbre. And from January 1994 to December 2002, they worked as a Group Leader and Fellow of Volwiler Society at AbbVie (Abbott Labs).
Some individuals on their team include Yu Liu - CMC Project Manager, Emily Chen - Funding & Corporate Development Director.
This person is not in any teams
TenNor Therapeutics
TenNor Therapeutics is a clinical-stage company with a sharp focus on discovery and development of differentiated products to address unmet medical needs in infectious disease area. The company possesses a novel multi-targeting drug conjugate platform and a globally protected new drug development portfolio.